ATF3 and melanoma: Moreover, it activates the P38/MAPK/ATF3 signaling pathway to stimulate IL-24 secretion by melanoma cells, which contributes to reshaping the immunosuppressive TME and enhancing CD8+ T cell-mediated immune responses (Fig. 7).